Hit enter to search or ESC to close
ERA4TBERA4TBERA4TB
  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
All Posts By

Andrea Garcia

EventNews

6th Consortium Meeting, 25-26th January 2023 – ERA4TB partners gather for a face-to-face event in Paris

On the 25th and 26th January, more than 100 representatives of ERA4TB partners had the…
Andrea Garcia
Andrea GarciaJanuary 30, 2023
Event

ERA4TB marks its halfway point with 6th Consortium meeting in Paris

On January 25th and 26th, the sixth Consortium Meeting will take place on the Campus…
Andrea Garcia
Andrea GarciaJanuary 23, 2023
EventNews

SAVE THE DATE: ERA4TB Webinar on Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives

ERA4TB is launching a series of webinars aimed at exploring key topics in relation to…
Andrea Garcia
Andrea GarciaOctober 17, 2022
Press

ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’

The article ‘How partnerships are driving new treatments for tuberculosis’ has just been published on World…
Andrea Garcia
Andrea GarciaSeptember 21, 2022
Event

ERA4TB 5th Consortium Meeting: First F2F meeting in Madrid after the pandemic

On June 20th and 21st the fifth Consortium Meeting took place in Madrid. The meeting…
Andrea Garcia
Andrea GarciaJune 22, 2022

Recent Posts

  • 6th Consortium Meeting, 25-26th January 2023 – ERA4TB partners gather for a face-to-face event in Paris
  • ERA4TB marks its halfway point with 6th Consortium meeting in Paris
  • SAVE THE DATE: ERA4TB Webinar on Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives
  • ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’
  • ERA4TB 5th Consortium Meeting: First F2F meeting in Madrid after the pandemic

Categories

  • Event
  • News
  • Press

TWITTER

ERA4TB ProjectFollow

Research consortium developing new treatments for TB European Regimen Accelerator for Tuberculosis Grant Agreement no. 853989 — ERA4TB https://t.co/BXboc1TV3r

ERA4TB Project
23h

We have just posted a news article on the ERA4TB website about the 6th ERA4TB consortium meeting that was held last week at the @institutpasteur in Paris. Read the article now to find out more:

https://bit.ly/3XMnoTb

Reply on Twitter 1620074787581329408Retweet on Twitter 16200747875813294081Like on Twitter 16200747875813294088Twitter 1620074787581329408
26 Jan

🎉As the 6th ERA4TB Consortium Meeting in Paris comes to an end we'd like to thank all participants for another successful event! We look forward to continuing our work towards better TB treatments over the next 3 years and to our next consortium meeting this summer!

#TB #H2020

Reply on Twitter 1618622786263715842Retweet on Twitter 161862278626371584211Like on Twitter 161862278626371584228Twitter 1618622786263715842
26 Jan

We conclude the 6th consortium meeting with comments from Gilla Kaplan and Francesca Conradie, our external Scientific Advisory Board members

We thank all the Consortium and SAB members for their excellent contributions!

#Tuberculosis #EUHealthResearch #H2020

Reply on Twitter 1618610944896294916Retweet on Twitter 16186109448962949165Like on Twitter 161861094489629491613Twitter 1618610944896294916
26 Jan

Today, the 6th Consortium Meeting of ERA4TB started with an overview of the pipeline status and discussions on each asset’s progression

#Tuberculosis #EUHealthResearch #H2020

Reply on Twitter 1618528773623906304Retweet on Twitter 16185287736239063049Like on Twitter 161852877362390630417Twitter 1618528773623906304
Retweet on TwitterERA4TB Project Retweeted
25 Jan

The management team of @IMI_ERA4TB, Carlos Díaz and Elena del Rey led a session on project management and sustainability at the 6th Consortium Meeting in Paris

@IHIEurope #Tuberculosis #EUHealthResearch #H2020

Reply on Twitter 1618338498993586176Retweet on Twitter 16183384989935861765Like on Twitter 161833849899358617610Twitter 1618338498993586176
Load More...
Acknowledgement:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.
The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.
Contact:
info@era4tb.org
The Project
  • About
  • Objectives
  • Ambitions
  • Structure
Consortium
  • Partners
  • Advisors
News
  • News
  • Newsletter
  • Events
  • Media
Result
  • Publications
  • Deliverables

© 2023 ERA4TB. About IMI - Disclaimer - Cookies Policy - Legal Notice

  • The Project
  • Consortium
  • News
    • Events
    • Press
    • Newsletter
    • Video Library
    • Blog
  • Results
  • TB Facts
  • SharePoint
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookies PolicyACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.